Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1821
IPSCIO Record ID: 4624
1. DxStrip HIV-1 and HIV-2, Rapid Test for HIV-1 and HIV-2, Catalogue # DSH3CS204, for in-vitro diagnostic use only.
2. AccuSpotâ„¢ Dengue Fever, Rapid Test for Dengue Fever IgM and IgG, Catalogue #ASDF-CS201, for in-vitro diagnostic use only.
3. Trade Secrets/Know-how/manufacturing support – Colloidal Gold Suspension /Colloidal Gold custom manufacturing business
'Licensed Technology' shall mean (i) DxStrip HIV-1 and HIV-2, Rapid Test for HIV1 and HIV-2, Catalogue # DSH3CS204; (ii) AccuSpotâ„¢ Dengue Fever, Rapid Test for Dengue Fever IgM and IgG, Catalogue #ASDF-CS201; and (iii) Trade Secrets/Know how/manufacturing support – Colloidal Gold Suspension /Colloidal Gold custom manufacturing business.
IPSCIO Record ID: 2219
Licensed Patent(s) shall mean United States Letters Patent No. 5,591,645. Patents relate to Rapid Manual Tests for hCG and LH analytes. Human chorionic gonadotropin or human chorionic gonadotropin (hCG) is a glycoprotein hormone produced in pregnancy that is made by the developing embryo after conception and later by the syncytiotrophoblast (part of the placenta).
IPSCIO Record ID: 2603
The term Licensed Products shall mean any in vitro diagnostic test, assay, method or kit, the development, manufacture, use or sale of which make use of the NASBA Technology, the Boom Technology and / or the NASBA and Boom Technology and are covered by one or more claims of the Patent rights.